Extracellular vesicles as modifiers of antibody‐drug conjugate efficacy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Extracellular vesicles as modifiers of antibody‐drug conjugate efficacy

Published:2021-02 Issue:4 Volume:10 Page:
ISSN:2001-3078
Container-title:Journal of Extracellular Vesicles
language:en
Short-container-title:Journal of Extracellular Vesicles

Author:

Barok Mark¹²,Puhka Maija³,Yazdi Narjes¹²,Joensuu Heikki¹²

Affiliation:

1. Helsinki University Hospital and University of Helsinki Helsinki Finland

2. Laboratory of Molecular Oncology University of Helsinki Biomedicum Helsinki Finland

3. Institute for Molecular Medicine FIMM EV and HiPrep Core University of Helsinki Helsinki Finland

Funder

Academy of Finland

Syöpäjärjestöt

Sigrid Juséliuksen Säätiö

Jane ja Aatos Erkon Säätiö

Helsingin Yliopisto

Publisher

Wiley

Subject

Cell Biology,Histology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jev2.12070

Reference131 articles.

1. Preclinical antitumor activity of a novel anti‐c‐KIT antibody‐drug conjugate against mutant and wild‐type c‐KIT‐positive solid tumors;Abrams T.;Clinical Cancer Research,2018

2. Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR

3. Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells

4. Microvesicles: Messengers and mediators of tumor progression

5. Extracellular Vesicles Shedding Promotes Melanoma Growth in Response to Chemotherapy;Andrade L. N. S.;Scientific Reports,2019

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Intracellular and Extracellular Vesicles in the Development of Therapy Resistance in Cancer;Current Pharmaceutical Design;2024-10

2. Precision targeting in oncology: The future of conjugated drugs;Biomedicine & Pharmacotherapy;2024-08

3. Progress and Innovative Combination Therapies in Trop-2-Targeted ADCs;Pharmaceuticals;2024-05-17

4. Comparison of trastuzumab emtansine, trastuzumab deruxtecan, and disitamab vedotin in a multiresistant HER2-positive breast cancer lung metastasis model;Clinical & Experimental Metastasis;2024-02-17

5. Extracellular vesicles as tools and targets in therapy for diseases;Signal Transduction and Targeted Therapy;2024-02-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3